The corner and wire hanging test results indicated that IL-17A-neutralizing mAb could improve the motor function compared with that of IgG isotype-treated mice with ischemic stroke (Figures 1E,G; p < 0.001, n = 6 per group). The gene discussed is IL17A; the disease is ischemic stroke.